
Beijing is investigating Bi Jingquan, a deputy chief of the economic affairs committee under China’s top political advisory body, for alleged law violations, according to a Thursday statement from the Central Commission for Discipline Inspection.
The anti-corruption watchdog gave no details about the suspected violations. Bi, 69, served as the chief of the China Food and Drug Administration from 2015 to 2018, when he introduced regulatory overhauls that spurred innovation in China’s pharmaceutical sector.
发表回复